首页> 外文会议>International Conference on Physical-Technical Problems of Nuclear Science, Energy Generation and Power Industry >Use of Technetium-99m-Labeled Methoxy-Isobutyl Isonitrile and Iodine 123-Labeled Phenyl-Methyl-Pentadecanoic Acid in the Diagnosis and Prognosis of Patients with Dilated Cardiomyopathy
【24h】

Use of Technetium-99m-Labeled Methoxy-Isobutyl Isonitrile and Iodine 123-Labeled Phenyl-Methyl-Pentadecanoic Acid in the Diagnosis and Prognosis of Patients with Dilated Cardiomyopathy

机译:在扩张心肌病患者的诊断和预后,在扩张患者的诊断和预后使用施用施用术 - 99m标记的甲氧基 - 异丁基甲基甲氧基 - 甲基 - 甲基 - 戊己酸

获取原文

摘要

The objective of this study is to assess perfusion and metabolic state of the left ventricular in patients with dilated cardiomyopathy (DCM) using scintigraphy with MIBI and BMIPP, as well as to develop the predictors of efficacy of cardiac resynchronization therapy (CRT). The study included 51 patients with DCM who underwent CRT. Correlation between the values of LV ESV after CRT and preoperative perfusion and metabolic defects sizes was detected. "Responders" and "non-responders" groups were significantly different from the perfusion and metabolic defects sizes. Myocardial perfusion-metabolic scintigraphy can be used as additional criteria for the selection of patients for CRT.
机译:本研究的目的是利用MIBI和BMIPP使用闪烁的心肌病(DCM)的患者评估左心室的灌注和代谢状态,以及开发心脏重新同步治疗(CRT)的疗效的预测因子。该研究包括51例DCM患者接受CRT。检测到CRT和术前灌注后LV ESV值与代谢缺陷尺寸之间的相关性。 “响应者”和“非响应者”群体与灌注和代谢缺陷大小不同。心肌灌注代谢闪烁闪烁扫描物可用作选择CRT患者的额外标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号